DAVA vs DOCS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

DAVA

34.5
AI Score
VS
DOCS Wins

DOCS

58.0
AI Score

Investment Advisor Scores

DAVA

35score
Recommendation
SELL

DOCS

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DAVA DOCS Winner
Forward P/E 2.0396 19.6078 DAVA
PEG Ratio 0.2833 0.5895 DAVA
Revenue Growth -8.4% 7.3% DOCS
Earnings Growth -21.4% -51.9% DAVA
Tradestie Score 34.5/100 58.0/100 DOCS
Profit Margin -56.1% 25.5% DOCS
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD DOCS

Relative Price Performance (Last 90 Days)

DAVA 1M: -4.9% · 3M: +4.7% DOCS 1M: +2.4% · 3M: +27.8%

Current Technical Phase

DAVA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.5 · Price: $2.91

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.2% over 20 days), RSI 54

RSI (14): 53.7 · Price: $25.58

Fundamentals Snapshot

Metric DAVA DOCS
Market Cap
Forward P/E 4.6 15.8
Trailing P/E 28.7
Revenue (TTM)
Revenue Growth -0.1% 0.1%
Gross Margin 0.2% 0.9%
Operating Margin 0.0% 0.2%
EPS -10.57 0.86
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DOCS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.